Hikal Limited Share Price & Analysis
₹189.62▼ -1.19%Updated 5 Jun 2026, 05:02 pm IST
LTP
₹189.62
-1.19%
Open
₹—
High
₹194.61
Low
₹189
Close
₹189.62
52W High
₹386
52W Low
₹146
Volume
160K
Lot Size
1
Sector
Healthcare
Market Cap
₹2K Cr
Face Value
₹2
Small Cap
Price Chart
Fundamentals
P/E
65.1
Sector P/E
48.9
P/B
1.97
EPS
₹-3.96
ROE
2.95%
ROCE
3.52%
D/E Ratio
—
Div Yield
0.73%
Book Value
₹97.2
−
Concerns
- ✗Currently loss-making (EPS ₹-4)
- ✗Low capital efficiency (ROCE 3.5%)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,783 | ₹4.3L Cr | 34.4 | 5.12 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹6,616 | ₹1.7L Cr | 66.1 | 10.48 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,416 | ₹1.5L Cr | 66.4 | 17.81 | 27.6 | 15.4 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,315 | ₹1.2L Cr | 59.5 | 12.62 | 22.1 | 17.9 | 0.88 |
| CIPLA Cipla Limited | ₹1,402 | ₹1.1L Cr | 27.3 | 3.29 | 12.4 | 16.6 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,091 | ₹1.1L Cr | 20 | 4.05 | 21.2 | 21.2 | 0.38 |
| DRREDDY Dr. Reddy's Laboratories Limited | ₹1,283 | ₹1.1L Cr | 25.4 | 2.83 | 11.8 | 13.6 | 0.16 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
HIKAL · as of Mar 2026
Promoters68.85%
FII5.70%▼0.36
DII3.80%▲0.32
Public21.65%▲0.04
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 68.85% | 68.85% | 68.85% | 68.85% | 68.85% | 68.85% |
| FII | 6.14% | 6.55% | 6.66% | 6.78% | 6.06% | 5.70% |
| DII | 3.15% | 3.53% | 3.17% | 3.58% | 3.48% | 3.80% |
| Public | 21.85% | 21.06% | 21.32% | 20.79% | 21.61% | 21.65% |
About Hikal Limited
Hikal is a partner to companies in the Pharmaceuticals, Crop Protection, and Specialty Chemicals industry. The company is in the business of supplying research services, active ingredients and intermediates for its customers. Hikal's manufacturing facilities have been inspected and approved by leading multinational companies in the Crop protection and Pharmaceutical sectors. The Crop protection facilities are located at Taloja and Mahad {Maharashtra). The Pharmaceutical manufacturing facilities are situated in Jigani (Bengaluru) and Panoli (Gujarat). Hikal's R & D facilities are located in Pune.[1]
Healthcare · Pharmaceuticals & Biotechnology
Related Analysis
Frequently Asked Questions
What is Hikal Limited share price today?▾
Hikal Limited (HIKAL) is currently trading at ₹189.62 on NSE, down 1.19% as of the last market session. Prices update daily after market close on MarketNetra.
Is Hikal Limited available in F&O (Futures & Options)?▾
Yes, Hikal Limited (HIKAL) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Hikal Limited 52-week high and low?▾
Hikal Limited's 52-week high is ₹386 and the 52-week low is ₹146. The current price of ₹189.62 is 50.9% below the 52W high.
What is Hikal Limited P/E ratio?▾
Hikal Limited's current P/E ratio is 65.1. This indicates the market is paying ₹65.1 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Hikal Limited options?▾
Hikal Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade HIKAL options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.